Drugs / PEG-Glucocerebrosidase
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00001410 | Oct 1993 → Dec 2001 | Gaucher disease | National Institute of Mental Health (NIMH) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PEG-Glucocerebrosidase | “A Phase I and II Study of PEG-Glucocerebrosidase in Patients With Type 1 or Type 3 Gaucher Disease” NCT00001410 ↗ |
| Modality | Protein / enzyme biologic | “enzyme replacement therapy using PEG- glucocerebrosidase” NCT00001410 ↗ |